NLE Respiratory Nursing — Chronic Obstructive & Restrictive Pulmonary DisordersSummary

COPD is a progressive, largely irreversible airflow limitation characterized by a forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio of <70% that is not fully reversible with bronchodilators. It represents an umbrella diagnosis encompassing chronic bronchitis and emphysema, which typically coexist. COPD is caused predominantly by cigarette smoking (primary cause globally), but in the Philippine context, biomass/cooking-fuel smoke exposure and occupational hazards (silica, asbestos) are significant contributors. The pathophysiology involves chronic airway inflammation, mucus-gland hypertrophy, airway narrowing, and progressive air trapping. COPD is the third leading cause of death globally and a major public health concern in the Philippines, particularly affecting lower-income populations with indoor biomass-fuel use.

Chronic bronchitis is clinically defined as a productive cough persisting for at least 3 months in 2 consecutive years. Pathophysiologically, it involves chronic inflammation of the airways, mucus-gland hypertrophy, excessive mucus production, and progressive airway narrowing leading to air trapping and impaired gas exchange. The classic clinical picture is the 'blue bloater'—a patient with cyanosis (bluish discoloration from hypoxemia), peripheral edema (from cor pulmonale), copious purulent sputum, productive cough, significant hypoxemia, hypercapnia (elevated CO2), and right-heart failure. These patients retain CO2 chronically and depend on hypoxemia as their respiratory stimulus. Assessment findings include barrel chest (from air trapping), decreased breath sounds, crackles, wheezing, use of accessory muscles, and late signs of cor pulmonale.

Emphysema involves destruction of the alveolar walls and loss of elastic recoil, creating enlarged air spaces (bullae) and irreversible air trapping. The alveolar-capillary interface is progressively destroyed, reducing surface area for gas exchange. Clinically, the 'pink puffer' presents with a barrel chest (increased anteroposterior diameter), pursed-lip breathing (a compensatory mechanism to keep airways open during expiration and reduce air trapping), minimal cough, marked dyspnea on exertion, prominent use of accessory muscles (neck and shoulder muscles), and a thin, wasted appearance. Gas exchange is less impaired than in bronchitis, so hypoxemia is relatively mild; hence the 'pink' appearance. Alpha-1 antitrypsin deficiency is a genetic cause seen in younger, non-smoking patients and is a classic NLE question stem. These patients typically have a hyperresonant chest to percussion and decreased breath sounds.

This is the single most critical safety principle in respiratory nursing for COPD patients. Chronic CO2 retainers have adapted to elevated PaCO2 levels; their respiratory drive is stimulated by hypoxemia rather than hypercapnia. Administering high-flow oxygen (>40% FiO2 or SpO2 >94%) suppresses the hypoxic drive, reducing ventilation and causing further CO2 retention and respiratory acidosis—a condition called 'CO2 narcosis' or 'hypercapnic respiratory failure.' The target SpO2 for COPD patients is 88–92%, markedly different from the standard 95–100% for non-retainers. Use low-flow oxygen devices (nasal cannula at 1–2 L/min) or, ideally, a Venturi mask for precise FiO2 control. NEVER withhold oxygen from a hypoxic COPD patient; instead, titrate carefully and monitor closely. This principle is a major NLE differentiator between expert nursing and unsafe practice.

Spirometry is the gold-standard diagnostic tool for COPD. The key diagnostic finding is a post-bronchodilator FEV1/FVC ratio <70% that does NOT significantly improve with bronchodilator administration (contrasting with asthma, which IS reversible). Additional findings include reduced FEV1 (indicating airflow obstruction severity) and hyperinflation (increased total lung capacity and functional residual capacity). Severity is staged by FEV1: mild (FEV1 ≥80% predicted), moderate (FEV1 50–79% predicted), severe (FEV1 30–49% predicted), and very severe (FEV1 <30% predicted). Chest X-ray often shows hyperinflation, flattened diaphragms, and increased anteroposterior diameter. ABGs typically show chronic respiratory acidosis with metabolic (renal) compensation: elevated PaCO2, elevated HCO3-, near-normal pH (reflecting renal compensation over time), and low PaO2.

Asthma is a chronic inflammatory airway disorder characterized by reversible bronchospasm, mucosal edema, and mucus plugging. Triggers include allergens, exercise, cold air, smoke, infection, and stress. The hallmark is reversibility—unlike COPD, airflow obstruction resolves with bronchodilators or anti-inflammatory therapy. Clinical manifestations include expiratory wheezing, cough (often nocturnal), chest tightness, dyspnea, and prolonged expiration. A critical assessment finding is the 'silent chest'—absence of audible wheeze in a severely distressed patient—which signals severe obstruction and impending respiratory failure; this is an ominous sign requiring immediate intervention. Status asthmaticus is a severe, prolonged asthma attack unresponsive to standard bronchodilators and is a medical emergency requiring ICU-level care. The nursing distinction between 'relievers' (short-acting bronchodilators for acute symptoms) and 'controllers' (inhaled corticosteroids for prevention) is fundamental to patient education.

Asthma medications are categorized by function: Relievers are short-acting beta-2 agonists (SABA) such as salbutamol/albuterol, used for acute bronchospasm. These work within minutes and are rescue medications. Side effects include tachycardia, tremor, jitteriness, and potential for tachyphylaxis with overuse. Controllers are preventive medications taken daily to maintain airway inflammation control and prevent exacerbations: inhaled corticosteroids (ICS) like fluticasone and beclomethasone are first-line, long-acting beta-2 agonists (LABA) such as salmeterol and formoterol (used only in combination with ICS, never as monotherapy), leukotriene modifiers like montelukast, and long-acting muscarinic antagonists. ICS requires mouth-rinsing post-inhalation to prevent oral candidiasis. For acute severe asthma, management includes oxygen, nebulized salbutamol plus ipratropium, systemic corticosteroids, and IV magnesium sulfate. Correct inhaler technique with a spacer is essential for drug delivery.

Bronchiectasis is permanent, abnormal dilation of the bronchi resulting from chronic infection and inflammation that destroys airway walls. In the Philippine setting, this often follows severe tuberculosis infection, recurrent respiratory infections, or cystic fibrosis. Pathophysiology involves loss of normal airway elastic tissue and smooth muscle, creating dilated, non-functional airways that cannot effectively clear secretions. The hallmark clinical presentation is a chronic, productive cough with copious amounts (often >100 mL/day) of thick, purulent, foul-smelling sputum, often exhibiting characteristic three-layer settling on standing. Associated findings include recurrent infections, hemoptysis, digital clubbing, and diffuse crackles on auscultation. High-resolution computed tomography (HRCT) is the diagnostic gold standard. The nursing priority is aggressive airway clearance through postural drainage, chest physiotherapy, adequate hydration, mucolytics, and nebulization. Patients require antibiotics during exacerbations, bronchodilators for symptomatic relief, and regular vaccination.

Restrictive diseases limit lung expansion and reduce lung volumes, contrasting with obstructive disease that limits airflow. Spirometry shows a reduced forced vital capacity (FVC) with a normal or increased FEV1/FVC ratio (>70%)—the opposite pattern to COPD. Causes include pulmonary fibrosis (idiopathic or occupational: silica, asbestos, coal dust), sarcoidosis, chest-wall deformities (kyphoscoliosis, severe obesity), and neuromuscular disease (myasthenia gravis, amyotrophic lateral sclerosis). Clinical manifestations include progressive exertional dyspnea, dry non-productive cough, fine 'Velcro' crackles on auscultation (characteristic of pulmonary fibrosis), digital clubbing, cyanosis, and reduced lung volumes on spirometry. Management is largely supportive: treat the underlying cause, supplemental oxygen for hypoxemia, pulmonary rehabilitation to optimize function, and for idiopathic pulmonary fibrosis, antifibrotic agents (pirfenidone, nintedanib). Prognosis is often poor; advance-care planning and palliative care are important components.

Pneumothorax is the presence of air in the pleural space, disrupting normal negative intrapleural pressure and causing partial or complete lung collapse. Types include: (1) Spontaneous—rupture of a subpleural bleb, classically in tall, thin young men; also from ruptured bullae in emphysema (secondary spontaneous); (2) Traumatic—from penetrating or blunt chest trauma, including an open ('sucking') chest wound allowing atmospheric air into the pleural space; and (3) Tension pneumothorax—a one-way valve mechanism allows air into the pleural space but prevents escape, causing progressive pressure buildup that collapses the ipsilateral lung and shifts the mediastinum, compressing the contralateral lung, heart, and great vessels. Tension pneumothorax is immediately life-threatening and requires emergency needle decompression. The normal intrapleural pressure is -5 cm H2O; tension physiology develops when pressure exceeds +5 to +10 cm H2O.

Tension pneumothorax is a life-threatening emergency requiring immediate recognition and intervention. Classic red-flag findings include tracheal deviation TOWARD the unaffected (non-collapsed) side, distended neck veins (jugular venous distension), severe hypotension, cyanosis, profound dyspnea, tachycardia, absent breath sounds on affected side, and hyperresonance to percussion. The tracheal deviation occurs because increased intrapleural pressure pushes mediastinal structures contralaterally. This is a clinical diagnosis—do NOT delay management waiting for chest X-ray. Immediate intervention: needle decompression using a large-bore needle (14–16 gauge) inserted in the 2nd intercostal space at the midclavicular line, followed by chest-tube insertion. As a bedside nurse, anticipate and prepare emergency equipment (needle decompression kit, chest-tube tray, oxygen). High-flow oxygen accelerates air reabsorption. Monitor respiratory status and vital signs continuously.

An open ('sucking') chest wound results from penetrating chest trauma and allows atmospheric air to enter the pleural space directly through the chest wall, bypassing normal airway mechanisms. This disrupts pleural pressure and causes rapid lung collapse. Immediate management includes applying an occlusive dressing (Vaseline gauze or sterile plastic) taped on THREE sides only. Taping only three sides creates a flutter-valve effect: during inspiration, negative intrapleural pressure allows the dressing to be sucked against the wound, sealing it; during expiration, positive intrapleural pressure pushes the dressing outward, allowing trapped air to escape. This one-way mechanism prevents tension development. CRITICAL: Taping all four sides is dangerous—it can trap air and convert the wound to a tension physiology requiring emergent needle decompression or dressing release. After stabilization with the three-sided dressing, definitive management includes chest-tube insertion and wound closure. Monitor for subcutaneous emphysema (air in subcutaneous tissues), respiratory distress, and vital sign changes.

Using Maslow's hierarchy and the ABCDE priority framework, COPD nursing management prioritizes: (1) Airway protection—position patient in high-Fowler's or leaning forward on overbed table (tripod position) to ease work of breathing; (2) Breathing optimization—teach pursed-lip breathing (inhale through nose, exhale slowly through pursed lips) to keep small airways patent longer and reduce air trapping, and diaphragmatic (abdominal) breathing to maximize ventilatory efficiency; (3) Gas exchange—controlled oxygen therapy titrated to SpO2 88–92%; (4) Airway clearance—adequate hydration to thin secretions, controlled coughing techniques, chest physiotherapy where indicated, and encourage mobilization; (5) Energy conservation—small, frequent, high-calorie meals (large meals crowd the flattened diaphragm and exacerbate dyspnea), rest periods between activities, and pacing of activities to prevent fatigue. Prevention of infection is crucial: pneumococcal vaccination (23-valent pneumococcal polysaccharide [PPSV23], then 13-valent pneumococcal conjugate [PCV13]), annual influenza vaccination, and early reporting of sputum changes (indicates potential exacerbation).

Cor pulmonale is right-heart failure resulting from chronic pulmonary hypertension secondary to chronic lung disease (particularly COPD with chronic hypoxemia). Chronic hypoxemia causes pulmonary vasoconstriction, increasing right-ventricular workload and eventually causing right-ventricular hypertrophy and failure. Clinical manifestations include peripheral edema (particularly lower extremities and sacrum), jugular venous distension, hepatomegaly, ascites, and the characteristic 'blue bloater' appearance in advanced COPD. This is a late-stage complication and poor prognostic indicator. Secondary polycythemia develops from chronic hypoxemia stimulating erythropoietin production, increasing red-blood-cell mass and hemoglobin. While this initially compensates for oxygen-carrying capacity, it increases blood viscosity, raising the risk of thrombosis and stroke. Nursing management includes monitoring for signs of heart failure, fluid restriction, diuretics as prescribed, and maximizing oxygenation. Recognize these as indicators of disease progression and incorporate advance-care planning.

A COPD exacerbation is acute worsening of symptoms characterized by increased dyspnea, increased sputum production, change in sputum color from baseline (particularly to yellow/green indicating infection), increased cough, and sometimes fever. Early recognition and intervention slow disease progression and prevent hospitalization. Patients must recognize early warning signs and seek care promptly. Management includes increased bronchodilators, systemic corticosteroids (prednisone typically 40–60 mg daily for 5–7 days, then taper; never stop abruptly after prolonged use), antibiotics if purulent sputum or fever present, oxygen therapy titrated to SpO2 88–92%, and chest physiotherapy. Monitor ABGs closely; if PaCO2 rises >50 mmHg or pH drops below 7.30, non-invasive ventilation (BiPAP/CPAP) or intubation may be indicated. Educate patients to recognize early exacerbation signs and contact healthcare providers before acute respiratory failure develops.

Smoking cessation is the single most effective intervention to slow COPD progression and prevent future development. Even in advanced disease, quitting reduces exacerbation frequency and slows FEV1 decline. The nurse must reinforce smoking cessation at every patient encounter, utilizing motivational interviewing, providing resources (nicotine replacement, pharmacotherapy like varenicline/bupropion, counseling services), and addressing barriers to quitting. In the Philippine context, indoor biomass/cooking-fuel smoke exposure is a significant contributor to COPD, particularly among lower-income households. Nursing assessment must address home environment: Are charcoal stoves used indoors? Is there adequate ventilation? Can alternative cooking methods be implemented? Can ventilation hoods or improved stove designs be introduced? Occupational exposure assessment is also critical: Does the patient work in occupational hazards (silica, asbestos, coal, agricultural exposure)? Can workplace modifications or protective equipment reduce exposure? Environmental control includes smoking ban in the home, improved ventilation, and avoidance of air pollution.

Airway clearance is a cornerstone of management in bronchiectasis, chronic bronchitis, and some severe asthma cases. Postural drainage uses gravity to facilitate drainage of secretions from specific lung lobes or segments. The patient is positioned so affected lobes drain toward the central airways, typically at 45-degree angles, for 15–20 minutes per session. Specific positions target different lobes: upper lobes (Trendelenburg position or leaning back), lower lobes (reverse Trendelenburg or leaning forward), and specific segments (various tilted positions). Chest physiotherapy (percussion and vibration) accompanies drainage: the therapist or caregiver uses cupped-hand percussion over the affected lung areas during inspiration and vibration during expiration to loosen secretions. Followed by controlled coughing to expectorate mobilized sputum. This technique is particularly crucial in bronchiectasis patients producing copious purulent sputum. Frequency depends on sputum volume and patient tolerance, ranging from once daily to multiple times daily. Teach patients and family members these techniques for home management. Ensure adequate hydration and consider mucolytics or nebulization to thin secretions before drainage.

Correct inhaler technique is crucial for therapeutic effectiveness. Many patients use inhalers incorrectly, significantly reducing drug delivery. Key steps for metered-dose inhalers (MDIs): (1) Shake the inhaler well; (2) Exhale completely to functional residual capacity; (3) Place the mouthpiece between lips or use a spacer device (highly recommended for most patients, particularly children and elderly); (4) Activate the inhaler while breathing in slowly and deeply; (5) Hold breath for 10–15 seconds to allow lung deposition; (6) Wait 30–60 seconds before second puff if indicated. A spacer (holding chamber) is a cylindrical tube attached to the MDI that creates a reservoir, allowing slower, more controlled inhalation and improving lung deposition from 10% (without spacer) to 20–30% (with spacer). Spacers are particularly beneficial for children, elderly patients, and those with poor coordination. After inhaled corticosteroid use, patients MUST rinse the mouth with water and spit out (do not swallow) to prevent oral candidiasis. Teach proper technique with return demonstration in the clinical setting.

Peak expiratory flow rate (PEFR) is the maximum velocity of airflow during forced expiration, measured in liters per minute using a portable peak flow meter. PEFR monitoring allows patients to objectively track asthma control. Baseline PEFR (patient's personal best) is established when asthma is well-controlled, then used as reference. A traffic-light action plan uses PEFR zones: GREEN zone (80–100% of personal best) indicates good control, continue current medications; YELLOW zone (50–80% of personal best) indicates caution, increase reliever use and monitor closely, consider increasing controller medications; RED zone (<50% of personal best) indicates medical emergency, use reliever immediately and seek emergency care. Patients record PEFR twice daily (morning and evening) and more frequently during exacerbations or when symptoms develop. This objective tool empowers patients to recognize deterioration early and seek timely intervention. PEFR is particularly useful for nocturnal asthma monitoring and exercise-induced asthma tracking.

COPD pathophysiology (airway inflammation, mucus hypersecretion, air trapping in bronchitis; alveolar destruction, loss of elastic recoil in emphysema) directly determines clinical presentation: bronchitis patients develop hypoxemia and hypercapnia from impaired gas exchange and CO2 retention ('blue bloater'), while emphysema patients have less hypoxemia due to preserved ventilation-perfusion matching ('pink puffer'). This distinction mandates different oxygen strategies: bronchitis patients require strict SpO2 88–92% (to avoid CO2 narcosis from suppressed hypoxic drive), while emphysema patients tolerate SpO2 closer to 90–92% safely. Understanding the pathophysiologic basis prevents oxygen-related complications and is foundational to safe nursing practice.

Spirometry results distinguish among obstructive and restrictive diseases: COPD shows FEV1/FVC <70% that is NOT fully reversible (post-bronchodilator), indicating permanent airflow obstruction; asthma shows FEV1/FVC <70% that IS fully reversible, reflecting airway inflammation without permanent structural damage; restrictive disease shows reduced FVC with normal/increased FEV1/FVC ratio (>70%), indicating volume limitation rather than airflow obstruction. This spirometry pattern recognition is essential for accurate diagnosis, guiding treatment approaches (irreversible vs. reversible), prognosis (COPD poor; asthma good with treatment), and patient education strategies. This is a cornerstone NLE concept.

In chronic COPD (particularly the 'blue bloater' phenotype), chronic hypoxemia persistently stimulates pulmonary vasoconstriction as a hypoxic response. This chronic increase in pulmonary vascular resistance elevates right-ventricular afterload, eventually causing right-ventricular hypertrophy and failure (cor pulmonale). Clinically, cor pulmonale manifests as peripheral edema, JVD, hepatomegaly, and ascites—signs of right-heart failure. Cor pulmonale indicates advanced disease with poor prognosis and shortened life expectancy. Nursing implications include close monitoring for signs of heart failure, fluid/sodium restriction, diuretics as prescribed, and early advance-care planning. This pathophysiologic cascade demonstrates the life-threatening consequences of unmanaged chronic hypoxemia.

Asthma's pathophysiology involves acute and chronic airway inflammation triggered by various stimuli (allergens, exercise, cold, infection). This inflammation causes three concurrent changes: smooth-muscle bronchospasm (rapid onset), mucosal edema, and excess mucus production. Together, these create airflow obstruction. Crucially, all three components are reversible: bronchodilators relieve bronchospasm, inflammation resolves with anti-inflammatory therapy (steroids), and mucus is cleared. This reversibility is the fundamental distinction from COPD and explains the reliever/controller medication strategy: relievers (bronchodilators) work acutely, while controllers (corticosteroids) address underlying inflammation. Understanding this relationship clarifies why PEFR improves rapidly with treatment, why asthma prognosis is excellent with adherence, and why LABA monotherapy is dangerous (fails to address inflammation, masking progression).

Bronchiectasis develops from chronic infections (TB, severe pneumonia) or cystic fibrosis that destroy airway structural integrity. This structural loss (loss of elastic tissue, smooth muscle destruction) creates permanently dilated airways that cannot effectively clear secretions. Stagnant secretions become infected, worsening inflammation and airway damage—a self-perpetuating cycle. Clinically, this manifests as copious purulent sputum, recurrent infections (exacerbations), and progressive airway destruction over years. The nursing priority—aggressive airway clearance via postural drainage, chest physiotherapy, and mucolytics—directly interrupts this cycle by promoting secretion evacuation, reducing infection risk, and preventing further airway damage. Understanding this vicious cycle explains why routine airway clearance is not optional but essential to disease management and prognosis.

Pneumothorax pathophysiology determines type and urgency: spontaneous pneumothorax results from bleb rupture (no trauma); traumatic from external injury; tension from a one-way valve allowing air in but not out. Type directly determines management: spontaneous small pneumothorax may resolve with observation alone; larger requires chest tube; traumatic pneumothorax requires chest tube and wound care; tension pneumothorax is an immediate emergency requiring needle decompression first, then chest tube. The one-way valve mechanism in tension pneumothorax creates life-threatening pressure buildup compressing the contralateral lung, heart, and great vessels—explaining the urgency. Recognizing pneumothorax type guides appropriate intervention: needle decompression for tension (not diagnostic tests), chest tube for symptomatic/large, observation for small asymptomatic. This type-management relationship is critical for NLE emergency scenarios.

An open ('sucking') chest wound allows atmospheric air into the pleural space, disrupting negative intrapleural pressure. Applying an occlusive dressing (Vaseline gauze or sterile plastic) re-seals the wound. The critical element is taping only THREE sides: this creates a flutter-valve effect. During inspiration, negative intrapleural pressure sucks the dressing against the wound, sealing it; during expiration, positive intrapleural pressure pushes the dressing outward, allowing trapped air to escape. This one-way valve prevents air accumulation and tension development. Conversely, taping all four sides completely seals the wound without escape valve—air becomes trapped in the pleural space, progressively increasing pressure until tension pneumothorax develops, requiring emergent needle decompression or dressing release. This three vs. four-side principle is a critical safety distinction and represents a common NLE 'test-tricky' scenario.

In chronic COPD with persistent CO2 retention, the respiratory control center adapts to chronically elevated PaCO2, becoming relatively insensitive to CO2 as a respiratory stimulus. Instead, hypoxemia becomes the primary driver of ventilation. Administering high-flow oxygen (raising SpO2 >94%) eliminates the hypoxic stimulus, causing ventilatory drive to decline and CO2 to accumulate further—a condition called CO2 narcosis or hypercapnic respiratory failure. This can cause acute respiratory acidosis (pH <7.30), altered mental status, and potentially respiratory arrest. Therefore, oxygen in COPD must be carefully titrated to target SpO2 88–92%, using low-flow devices or Venturi masks for precise control. Never withhold oxygen from a hypoxic patient; instead, titrate methodically and monitor closely. This relationship between CO2 retention, hypoxic drive, and oxygen titration is the single most important safety principle in respiratory nursing and is heavily weighted in NLE examinations.

In emphysema and severe air trapping, small airways collapse during expiration due to loss of elastic recoil and positive intrapleural pressure. Pursed-lip breathing (exhale against pursed lips) creates back-pressure in the airways, maintaining positive pressure throughout expiration and preventing early small-airway collapse. This allows more complete emptying of trapped air during expiration, reducing hyperinflation and the work of breathing. Over time, this technique improves ventilatory efficiency and reduces dyspnea sensation. Mechanistically, pursed-lip breathing increases expiratory time and maintains airway patency, partially compensating for the structural airway loss in emphysema. Teaching this technique is a cornerstone of COPD/emphysema nursing and directly improves patient comfort and exercise tolerance.

Asthma medications are functionally categorized as relievers (rescue—short-acting bronchodilators for acute symptoms) or controllers (preventers—daily anti-inflammatory therapy). This distinction is crucial for patient understanding: relievers work within minutes during acute bronchospasm (blue inhaler in Australia, grey in the UK); controllers prevent exacerbations and maintain inflammation control but work slowly over days to weeks. Patients must understand that controllers are for daily maintenance regardless of symptoms, while relievers are for acute symptom episodes. Confusion about this distinction (e.g., using controller as reliever or vice versa) leads to poor adherence, inadequate inflammation control, and exacerbation risk. Clear education using simple language ('blue for rescue, brown for regular') improves adherence and asthma outcomes. This conceptual distinction directly impacts patient self-management and NLE educational questions.

IMMEDIATE PRIORITY: Reduce oxygen flow from 10 L/min to low-flow (1–2 L/min nasal cannula or 24–28% via Venturi mask) while closely monitoring SpO2 and respiratory status. RATIONALE: Mr. Santos demonstrates classic CO2 narcosis from excessive oxygen therapy. His chronic respiratory acidosis (pH 7.32 with elevated PaCO2 62 and HCO3- 32 reflects metabolic compensation) indicates he is a CO2 retainer with hypoxic drive dependency. High-flow oxygen (10 L/min) has suppressed his hypoxic ventilatory drive, causing further CO2 retention and respiratory acidosis. His confusion and drowsiness are signs of CO2 narcosis. His SpO2 of 82% is suboptimal but was deteriorating because ventilation was declining—not because oxygen was inadequate. Reduce oxygen to achieve target SpO2 88–92%; titrate carefully upward only if SpO2 drops below 88%. Monitor ABG closely; recheck in 1–2 hours. Contact the physician immediately regarding the altered mental status and elevated PaCO2. This scenario illustrates the critical safety principle that in CO2 retainers, more oxygen is NOT better and can precipitate life-threatening respiratory failure.

NURSING ASSESSMENT: Ms. Reyes' asthma control is inadequate—she is in the YELLOW zone (50–80% of personal best), indicating caution with potential progression to RED zone. Frequent reliever use (almost daily) and nocturnal symptoms suggest uncontrolled inflammation rather than occasional symptoms. NURSING DIAGNOSES: Ineffective airway clearance related to inflammation and bronchospasm; Ineffective health maintenance related to inadequate controller medication use. EDUCATIONAL INTERVENTIONS: (1) Assess current controller therapy—is she taking inhaled corticosteroid daily as prescribed? If not, address barriers to adherence (cost, side effects, misunderstanding that controllers aren't for 'rescue'). (2) Reinforce that frequent reliever use indicates inadequate inflammation control, not merely need for more rescue medication. (3) Teach the YELLOW zone action plan: increase reliever use, monitor closely, and contact healthcare provider to adjust controller medication (likely increase ICS or add LABA in combination). (4) Verify correct inhaler technique with return demonstration—assess for common errors (not shaking MDI, not holding breath after inhalation, not using spacer). (5) Identify and manage asthma triggers: allergies, exercise, cold air, occupational exposures, stress. (6) Teach PEFR self-monitoring twice daily; record in diary to track trends. (7) Advise seeking urgent care if PEFR drops to RED zone (<50% personal best) or she experiences severe dyspnea despite reliever use. This scenario demonstrates the reliever/controller distinction and the importance of empowering patients with objective monitoring and recognition of inadequate control.

PRIORITY NURSING DIAGNOSIS: Ineffective airway clearance related to excessive secretion production and damaged airway clearance mechanisms. PRIORITY INTERVENTIONS: (1) AIRWAY CLEARANCE—postural drainage + chest physiotherapy (percussion and vibration). Assess which lung segments are most affected (if lower lobes, use reverse Trendelenburg; if upper lobes, use Trendelenburg or reclined position). Position patient at 45-degree angle for 15–20 minutes, then perform chest physiotherapy (percuss and vibrate during inspiration) to loosen secretions, followed by controlled coughing to expectorate. Repeat 2–3 times daily or as tolerated. (2) SECRETION THINNING: Ensure adequate hydration (encourage 2–3 L fluid daily if not contraindicated), use nebulized saline or mucolytics (N-acetylcysteine) to thin secretions before drainage. (3) BREATHING OPTIMIZATION: Position high-Fowler's between drainage sessions; teach pursed-lip breathing if dyspneic. (4) COMFORT/SLEEP: Schedule postural drainage in morning and early evening to minimize nocturnal coughing; provide adequate pain control if pleurisy present. (5) INFECTION PREVENTION: Administer antibiotics as prescribed (for exacerbations with fever/increased purulence); ensure pneumococcal and annual influenza vaccination. (6) TEACH HOME PROGRAM: Educate patient and family to perform daily postural drainage and coughing regimen at home—this is essential for long-term management and prevents frequent hospitalizations. (7) MONITOR: Track sputum volume/character changes; report significant increases or color changes (indicators of acute infection). This scenario prioritizes the hallmark nursing intervention in bronchiectasis—aggressive airway clearance—which directly prevents complications and improves quality of life.

IMMEDIATE NURSING ACTIONS: (1) VERIFY SpO2: Check current SpO2 immediately using pulse oximetry. If <88%, provide supplemental oxygen via nasal cannula (start 1–2 L/min) to bring SpO2 to target 88–92%; if 88–92% already, monitor without additional oxygen. (2) ASSESS SEVERITY: Evaluate for signs of severe respiratory distress or respiratory failure: confusion, inability to speak in full sentences, paradoxical abdominal breathing (suggests severe fatigue), cyanosis, altered mental status. If present, alert physician immediately; patient may require non-invasive ventilation (BiPAP). (3) POSITION: High-Fowler's or tripod position (leaning forward on overbed table) to ease work of breathing. (4) BREATHING TECHNIQUE: If patient not already pursed-lip breathing, teach or reinforce: breathe in through nose for count of 2, exhale through pursed lips for count of 4. This maintains airway patency and reduces air trapping. Praise compliance. (5) ABG: Establish baseline ABG if possible (not immediately; after initial stabilization). Expect chronic respiratory acidosis with metabolic compensation (elevated PaCO2, high HCO3-, near-normal pH). (6) MEDICATION: Administer bronchodilators (short-acting beta-agonist +/- anticholinergic) via nebulizer if prescribed and acute exacerbation suspected. (7) IV ACCESS and ECG: Establish IV line and obtain 12-lead ECG to assess for acute cardiac involvement (cor pulmonale, arrhythmias). (8) OXYGEN MONITORING: Set pulse oximetry alarm limits at 88–92% SpO2 (NOT standard 95–100%) to alert staff to both hypoxemia and oxygen excess. (9) COMMUNICATE: Notify physician of admission and baseline status. This scenario illustrates the nuanced oxygen management in emphysema and the distinction between severe COPD and acute respiratory failure.

IMMEDIATE NURSING PRIORITY: Status asthmaticus—severe, prolonged asthma attack unresponsive to standard bronchodilators. This is a MEDICAL EMERGENCY requiring ICU-level care. IMMEDIATE ACTIONS: (1) HIGH-FLOW OXYGEN: Provide oxygen to target SpO2 ≥90% (in acute asthma, higher SpO2 is appropriate; oxygen does not suppress hypoxic drive as in COPD). (2) NOTIFY PHYSICIAN STAT: Patient may require IV corticosteroids, IV beta-2 agonists, IV magnesium sulfate, and possibly intubation and mechanical ventilation. (3) IV ACCESS: Establish peripheral IV line for medications. (4) CONTINUOUS MONITORING: Cardiac monitor, pulse oximetry, respiratory rate monitoring. (5) PREPARE FOR INTUBATION: Alert respiratory therapy; ensure emergency equipment is at bedside. WHY ABSENCE OF WHEEZING IS OMINOUS: The absence of audible wheezing in a severely distressed, dyspneic patient is a 'silent chest'—a RED FLAG indicating severe airway obstruction. Wheezing occurs when air moves through narrowed airways; complete obstruction produces no airway sounds. The 'silent chest' paradoxically indicates MORE severe obstruction than wheezing, not less. This patient has critical airflow limitation with impending respiratory failure. Combined with speaking only in single words (severe dyspnea), accessory muscle use, RED zone peak flow, and hypoxemia, this patient is in danger of respiratory arrest. Many providers mistake 'no wheeze' for 'improved asthma'—this is a dangerous misinterpretation. Education must emphasize: in acute asthma with distress, PRESENCE of wheeze = better than absence; ABSENCE of wheeze = ominous. This scenario teaches critical assessment interpretation and emergency response.

IMMEDIATE DIAGNOSIS: Open ('sucking') chest wound with possible tension pneumothorax developing (evidenced by tracheal deviation to RIGHT, indicating mediastinal shift away from the collapsed LEFT lung, increasing pressure). This is a LIFE-THREATENING EMERGENCY. IMMEDIATE ACTIONS IN ORDER: (1) SEAL THE WOUND—OCCLUSIVE DRESSING TAPED ON THREE SIDES: Quickly apply sterile Vaseline gauze or transparent sterile plastic over the wound opening. This immediately stops air entry through the chest wall. CRITICAL: Tape on THREE sides only (typically tape the top, left, and right sides; leave bottom side loose). This creates a FLUTTER-VALVE effect: negative intrapleural pressure during inspiration sucks the dressing against the wound, sealing it; positive pressure during expiration pushes the dressing outward, allowing trapped air to escape WITHOUT building tension. (2) HIGH-FLOW OXYGEN: Provide 100% oxygen via non-rebreather mask to increase oxygen delivery and speed air reabsorption from pleural space. (3) POSITION: Upright (semi-Fowler's if cardiovascular stable) to ease breathing. (4) IV ACCESS: Establish two large-bore IVs for fluid resuscitation (anticipate hemorrhage from the wound). (5) NOTIFY SURGEON STAT: This patient needs immediate operative intervention for wound closure and assessment of thoracic structures. (6) PREPARE FOR NEEDLE DECOMPRESSION: If signs of tension pneumothorax worsen (worsening hypotension, JVD, severe tachycardia, absent breath sounds), perform needle decompression at 2nd ICS midclavicular line with large-bore needle, then chest-tube insertion. (7) CONTINUOUS MONITORING: Vital signs, SpO2, respiratory status, heart sounds for muffled sounds (hemothorax). CRITICAL ERROR TO AVOID: Do NOT tape all four sides of the dressing—this completely seals the wound without escape valve, trapping air in the pleural space and converting simple pneumothorax to TENSION pneumothorax, causing cardiovascular collapse. The three-sided dressing is the key life-saving intervention. This scenario demonstrates the dramatic, time-sensitive nursing response to an open chest wound.

NURSING ASSESSMENT: COPD exacerbation suspected—increased dyspnea/reliever use, increased sputum with color change (green = suggests bacterial infection), fever. These are early exacerbation signs requiring prompt intervention to prevent acute respiratory failure and hospitalization. NURSING DIAGNOSES: Ineffective airway clearance related to increased secretion production; Risk for infection progression; Deficient knowledge regarding exacerbation recognition and prevention. IMMEDIATE INTERVENTIONS: (1) NOTIFY PHYSICIAN: Report exacerbation signs. Expect orders for: increased bronchodilators (may switch to nebulized or increase frequency), systemic corticosteroids (prednisone typically 40–60 mg daily x 5–7 days, then taper), antibiotics (if purulent sputum or fever), and possibly ABG if respiratory status deteriorates. (2) EDUCATE ON CURRENT EXACERBATION: Emphasize that early recognition and treatment prevent hospitalization and slow COPD progression. Review current symptom changes and their significance. (3) VACCINATION—PRIORITY: Mrs. Tan has NOT received pneumococcal or influenza vaccines—major gaps in preventive care. Administer: (a) Pneumococcal vaccine: Give PCV13 first (if never received), then PPSV23 1 year later (if age ≥65 or has chronic disease). If she already received PPSV23, may give PCV13 now or wait 1 year based on prior history. (b) Influenza vaccine: Administer now (if flu season) and annually. Emphasize vaccines reduce exacerbation risk and prevent hospitalizations. (4) SMOKING ASSESSMENT: Ask current smoking status. If smoker, reinforce cessation at every visit; provide resources (cessation programs, nicotine replacement, medications). (5) AIRWAY CLEARANCE: During exacerbation, encourage hydration (2–3 L daily if not contraindicated), teach or reinforce controlled coughing, and consider chest physiotherapy if sputum volume high. (6) ACTIVITY/REST: Teach energy conservation—rest between activities, avoid triggers (pollution, cigarette smoke). (7) MEDICATION ADHERENCE: Verify tiotropium taken daily (not PRN); explain long-acting maintenance therapy prevents exacerbations. (8) FOLLOW-UP: Schedule reassessment in 3–5 days to ensure exacerbation resolving; if worsening (increased dyspnea, altered mental status, SpO2 declining despite oxygen), refer to hospital. This scenario emphasizes early recognition and aggressive management of exacerbations, vaccination gaps, and patient education.

PATIENT-FRIENDLY EXPLANATION: 'Good question. Here's why meals matter with your lungs: When you eat a large meal, your stomach expands and pushes UP on your diaphragm—that's the muscle under your lungs that helps you breathe. Think of it like this: if you have a big, inflated balloon under your lungs, there's less room for your lungs to expand when you try to breathe in. Your breathing becomes harder, and you feel more short of breath. But if you eat smaller meals 5–6 times a day instead of three big ones, your stomach stays less full. This leaves more room for your lungs and diaphragm to work properly, making breathing easier. Plus, smaller, more frequent meals give your body steady energy without the big digestive load. So instead of breakfast-lunch-dinner, try eating a small meal or healthy snack every 2–3 hours—maybe a banana and yogurt, a small sandwich, some soup, cheese and crackers. This way, you eat the same total food but spread throughout the day. Your breathing will feel much easier, and you'll have better energy for your daily activities.' FOLLOW-UP TEACHING: Have Mr. Gomez identify specific small, high-calorie foods he enjoys; write a sample day's small meals to take home. Assess his current eating pattern and barriers (cost, cooking ability, time). Reinforce this is a practical change that directly improves his comfort and daily function—a win-win. This scenario teaches the skill of translating medical concepts into understandable language for patients, improving adherence to dietary recommendations.